Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Wai Yuen Tong Medicine Holdings Limited ( (HK:0897) ).
Wai Yuen Tong Medicine Holdings Limited has announced a board meeting scheduled for November 24, 2025, to discuss and approve the interim results for the six months ending September 30, 2025, and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:0897) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Wai Yuen Tong Medicine Holdings Limited stock, see the HK:0897 Stock Forecast page.
More about Wai Yuen Tong Medicine Holdings Limited
Wai Yuen Tong Medicine Holdings Limited is a company incorporated in Bermuda, primarily operating in the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine and healthcare products.
Average Trading Volume: 1,161,135
Technical Sentiment Signal: Buy
Current Market Cap: HK$489.4M
Find detailed analytics on 0897 stock on TipRanks’ Stock Analysis page.